Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Long non-coding RNA NEAT1 promotes colorectal cancer progression by regulating miR-205-5p/VEGFA axis
Huijie Liu et al.
HUMAN CELL (2020)
LncRNA ZEB1-AS1 regulates colorectal cancer cells by miR-205/YAP1 axis
Zhong Jin et al.
OPEN MEDICINE (2020)
LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p
Hanzhang Zhu et al.
PANCREATOLOGY (2020)
Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin
Anupam Dhasmana et al.
SCIENTIFIC REPORTS (2020)
An estimate of the total number of true human miRNAs
Julia Alles et al.
NUCLEIC ACIDS RESEARCH (2019)
Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
Xin Lai et al.
NUCLEIC ACIDS RESEARCH (2019)
MiR-205 mediated APC regulation contributes to pancreatic cancer cell proliferation
Rui-Feng Qin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Identification of FBXW7α-regulated genes in M1-polarized macrophages in colorectal cancer by RNA sequencing
Yupeng Long et al.
SAUDI MEDICAL JOURNAL (2019)
miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation
Changpo Ma et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
miR-205 targets runt-related transcription factor 2 to inhibit human pancreatic cancer progression
Lu Zhuang et al.
ONCOLOGY LETTERS (2019)
Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data
Weijun Liu et al.
GENOME BIOLOGY (2019)
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis
Yasutaka Yamada et al.
JOURNAL OF HUMAN GENETICS (2018)
Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
Fan Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs
Maria Fragiadaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
miR-205-5p/PTK7 axis is involved in the proliferation, migration and invasion of colorectal cancer cells
Shuo Chen et al.
MOLECULAR MEDICINE REPORTS (2018)
miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression
Ping Chu et al.
ONCOLOGY LETTERS (2018)
MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab
Alessandra Cataldo et al.
Oncotarget (2018)
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance
Xin Lai et al.
THERANOSTICS (2018)
Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells
Hui Lyu et al.
BIOLOGICAL PROCEDURES ONLINE (2018)
The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
Max Michael Traeger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Ultrasound-targeted microbubble destruction-mediated miR-205 enhances cisplatin cytotoxicity in prostate cancer cells
Dingwen Qin et al.
MOLECULAR MEDICINE REPORTS (2018)
miR-205 Regulates Basal Cell Identity and Stem Cell Regenerative Potential During Mammary Reconstitution
Yang Lu et al.
STEM CELLS (2018)
Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol
Faezeh Asghari et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
Prashanth K. B. Nagesh et al.
CANCERS (2018)
Expression of miR-205 in renal cell carcinoma and its association with clinicopathological features and prognosis
X. -W. Xu et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2018)
MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas
Olivera Stojadinovic et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)
MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo
Yuanyuan Zeng et al.
ONCOTARGET (2017)
MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer
Eva Karamitopoulou et al.
MODERN PATHOLOGY (2017)
被撤回的出版物: microRNA-205 acts as a tumor suppressor and directly targets YAP1 in glioma (Retracted article. See vol. 26, 2022)
Tao Ji et al.
MOLECULAR MEDICINE REPORTS (2017)
EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer
Goutam Mondal et al.
MOLECULAR PHARMACEUTICS (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer
Jun Wei et al.
JOURNAL OF OVARIAN RESEARCH (2017)
miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells
Zhihong Zhuo et al.
ONCOTARGET (2017)
Hypoxia inducible factors in hepatocellular carcinoma
Chu Chen et al.
ONCOTARGET (2017)
Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression
Juanni Li et al.
SCIENTIFIC REPORTS (2017)
MicroRNA-205 Mediates Proteinase-Activated Receptor 2 (PAR2) -Promoted Cancer Cell Migration
Xu Yang et al.
CANCER INVESTIGATION (2017)
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
Amit Kumar Chaudhary et al.
CANCER LETTERS (2017)
MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma
J. Canueto et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
MicroRNA-205 increases the sensitivity of docetaxel in breast cancer
Yang Cai et al.
ONCOLOGY LETTERS (2016)
Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma
Xiao Yue et al.
JOURNAL OF NEUROSURGERY (2016)
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer
Lei Huo et al.
MODERN PATHOLOGY (2016)
Understanding microRNA-mediated gene regulatory networks through mathematical modelling
Xin Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
Y. Hu et al.
CELL DEATH & DISEASE (2016)
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205-PROX1 mechanism
Trang Nguyen-Vu et al.
ONCOTARGET (2016)
Systems biology, emergence and antireductionism
Srdjan Kesic
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2016)
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
Amanda Shea et al.
CANCER MEDICINE (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Emerging role of microRNA-21 in cancer
Yin-Hsun Feng et al.
BIOMEDICAL REPORTS (2016)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer
Rika Nishikawa et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Survival and low-grade glioma: the emergence of genetic information
Elizabeth B. Claus et al.
NEUROSURGICAL FOCUS (2015)
MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression
Haige Zhang et al.
ONCOLOGY REPORTS (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
miRDB: an online resource for microRNA target prediction and functional annotations
Nathan Wong et al.
NUCLEIC ACIDS RESEARCH (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
Yi Shu et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Diagnostic and Prognostic Value of miR-205 in Colorectal Cancer
Ayla Valinezhad Orang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Insights into the Diverse Roles of miR-205 in Human Cancers
Ayla Valinezhad Orang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4
Ming Cui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA
Ming Cui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
Marzia Pennati et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
Anupama Mittal et al.
BIOMATERIALS (2014)
HER2 testing: Current status and future directions
Edith A. Perez et al.
CANCER TREATMENT REVIEWS (2014)
Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives
Chenguang Zhou et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
Volker Baumann et al.
FUTURE MEDICINAL CHEMISTRY (2014)
MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways
Shi-Yun Cui et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis
Chi-Hong Chao et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer
Alakesh Bera et al.
PLOS ONE (2014)
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Peijing Zhang et al.
NATURE COMMUNICATIONS (2014)
Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
Jin Wang et al.
JOURNAL OF CANCER (2014)
miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth
Ning Wang et al.
ASIAN JOURNAL OF ANDROLOGY (2013)
miRNA-205 affects infiltration and metastasis of breast cancer
Zhouquan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
Z. Hagman et al.
BRITISH JOURNAL OF CANCER (2013)
miRNA profiling in pancreatic cancer and restoration of chemosensitivity
Saurabh Singh et al.
CANCER LETTERS (2013)
miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer
Junchao Cai et al.
CANCER RESEARCH (2013)
MiR-205 in cancer: An angel or a devil?
Ai-Ying Qin et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2013)
MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals
Christelle Bruegger et al.
EXPERIMENTAL DERMATOLOGY (2013)
Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma
Pengyu Cao et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Downregulation of miR-17∼92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTEN
Ting Shuang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer
Berlinda Verdoodt et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
Yat-Yuen Lim et al.
JOURNAL OF CELL SCIENCE (2013)
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC
Hideki Terai et al.
MOLECULAR CANCER RESEARCH (2013)
MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathway
Dongmei Wang et al.
NATURE CELL BIOLOGY (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
K. Boll et al.
ONCOGENE (2013)
miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma
Ning Su et al.
ONCOLOGY REPORTS (2013)
miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN
Lin Lei et al.
ONCOLOGY REPORTS (2013)
MicroRNA-based regulation of epithelial-hybridmesenchymal fate determination
Mingyang Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Hepatitis B Virus X Protein Inhibits Tumor Suppressor miR-205 through Inducing Hypermethylation of miR-205 Promoter to Enhance Carcinogenesis
Tao Zhang et al.
NEOPLASIA (2013)
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
Martin Puhr et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma
Zhaohui Luo et al.
BMC MEDICAL GENOMICS (2012)
MicroRNA profiling of a CD133+ spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
Eun Ji Nam et al.
BMC MEDICAL GENOMICS (2012)
Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
Y. Xu et al.
BRITISH JOURNAL OF CANCER (2012)
MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
Changju Qu et al.
CELL CYCLE (2012)
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development
P. Gandellini et al.
CELL DEATH AND DIFFERENTIATION (2012)
TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death
M. Seillier et al.
CELL DEATH AND DIFFERENTIATION (2012)
Inducible deletion of epidermal Dicer and Drosha reveals multiple functions for miRNAs in postnatal skin
Monica Teta et al.
DEVELOPMENT (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
The interaction of hepatic lipid and glucose metabolism in liver diseases
Lars P. Bechmann et al.
JOURNAL OF HEPATOLOGY (2012)
Epithelial-mesenchymal transition in malignant mesothelioma
Ambrogio Fassina et al.
MODERN PATHOLOGY (2012)
Loss of microRNA-205 expression is associated with melanoma progression
Shujing Liu et al.
LABORATORY INVESTIGATION (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A
Xiao Yue et al.
ONCOLOGY REPORTS (2012)
Prognostic Significance of miR-205 in Endometrial Cancer
Mihriban Karaayvaz et al.
PLOS ONE (2012)
Downregulation of miR-205 Modulates Cell Susceptibility to Oxidative and Endoplasmic Reticulum Stresses in Renal Tubular Cells
Shiyo Muratsu-Ikeda et al.
PLOS ONE (2012)
miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells
Hong Xie et al.
PLOS ONE (2012)
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer
Paola Tucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse
Sophie Giusiano et al.
PROSTATE (2012)
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene
A. Fleischmann et al.
PROSTATE (2012)
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy
Murali M. Yallapu et al.
BIOMATERIALS (2011)
Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling
Andrew D. Patterson et al.
CANCER RESEARCH (2011)
MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer
Shahana Majid et al.
CANCER RESEARCH (2011)
let-7 and miR-17-92: Small-sized major players in lung cancer development
Hirotaka Osada et al.
CANCER SCIENCE (2011)
miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
Altaf A. Dar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells
Kayoko Matsushima et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Nucleic Acid-Gold Nanoparticle Conjugates as Mimics of microRNA
Liangliang Hao et al.
SMALL (2011)
Targets for human encoded microRNAs in HBV genes
Fang-li Wu et al.
VIRUS GENES (2011)
MicroRNA-205-Directed Transcriptional Activation of Tumor Suppressor Genes in Prostate Cancer
Shahana Majid et al.
CANCER (2010)
MicroRNA-mediated control in the skin
R. Yi et al.
CELL DEATH AND DIFFERENTIATION (2010)
Small Players With Big Roles: MicroRNAs as Targets to Inhibit Breast Cancer Progression
Stephanie B. Greene et al.
CURRENT DRUG TARGETS (2010)
The Etiology and Epidemiology of Merkel Cell Carcinoma
Maria Agelli et al.
CURRENT PROBLEMS IN CANCER (2010)
A putative role for microRNA-205 in mammary epithelial cell progenitors
Stephanie B. Greene et al.
JOURNAL OF CELL SCIENCE (2010)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
The ups and downs of miR-205 Identifying the roles of miR-205 in mammary gland development and breast cancer
Stephanie B. Greene et al.
RNA BIOLOGY (2010)
Bcl-2 as a Predictive Factor for Biochemical Recurrence after Radical Prostatectomy: An Interim Analysis
In-Chang Cho et al.
CANCER RESEARCH AND TREATMENT (2010)
MicroRNAs in Cancer
Yong Sun Lee et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1
Heesang Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Low-Density Lipoprotein Receptor-Related Protein 1 Promotes Cancer Cell Migration and Invasion by Inducing the Expression of Matrix Metalloproteinases 2 and 9
Heesang Song et al.
CANCER RESEARCH (2009)
microRNA-205 Regulates HER3 in Human Breast Cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2009)
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
Paolo Gandellini et al.
CANCER RESEARCH (2009)
Suppression of cell growth and invasion by miR-205 in breast cancer
Hailong Wu et al.
CELL RESEARCH (2009)
Hepatitis B Virus DNA Levels and Outcomes in Chronic Hepatitis B
Chien-Jen Chen et al.
HEPATOLOGY (2009)
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non-Small-Cell Lung Carcinoma
Danit Lebanony et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2
Wha Ja Cho et al.
MOLECULES AND CELLS (2009)
DIANA-microT web server: elucidating microRNA functions through target prediction
M. Maragkakis et al.
NUCLEIC ACIDS RESEARCH (2009)
The emerging role of the Hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals
Qi Zeng et al.
CANCER CELL (2008)
A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
Si Tuen Lee-Hoeflich et al.
CANCER RESEARCH (2008)
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer
Sara Ladu et al.
GASTROENTEROLOGY (2008)
MicroRNA expression profiles of esophageal cancer
Andrew Feber et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia
Jia Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
Altered microRNA expression confined to specific epithelial cell Subpopulations in breast cancer
Lorenzo F. Sempere et al.
CANCER RESEARCH (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Micro-RNA profiling in kidney and bladder cancers
Fedra Gottardo et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
A mammalian microRNA expression atlas based on small RNA library sequencing
Pablo Landgraf et al.
CELL (2007)
MicroRNA expression profiles in head and neck cancer cell lines
Nham Tran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy
Tateki Yoshino et al.
CLINICAL CANCER RESEARCH (2006)
The current epidemiology of cutaneous malignant melanoma
M Berwick et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Influence of liver cancer on lipid and lipoprotein metabolism
Jingting Jiang et al.
LIPIDS IN HEALTH AND DISEASE (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
WG Jiang et al.
BMC CANCER (2006)
Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies
M Mimeault et al.
CARCINOGENESIS (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Extensive modulation of a set of microRNAs in primary glioblastoma
SA Ciafrè et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNA expression in zebrafish embryonic development
E Wienholds et al.
SCIENCE (2005)
Merkel cell carcinoma: Changing incidence trends
NC Hodgson
JOURNAL OF SURGICAL ONCOLOGY (2005)
Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer
V Diéras et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer
AK Nowak et al.
LANCET ONCOLOGY (2004)
Prostate specific antigen gene regulation by androgen receptor
J Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase
HK Lin et al.
EMBO JOURNAL (2002)
The genetics of the E2F family of transcription factors: shared functions and unique roles
J DeGregori
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2002)
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
J Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma
R Motley et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas
IH Chaudhry et al.
HISTOPATHOLOGY (2001)
Angiomotin:: An angiostatin binding protein that regulates endothelial cell migration and tube formation
B Troyanovsky et al.
JOURNAL OF CELL BIOLOGY (2001)
Deregulated E2F transcriptional activity in autonomously growing melanoma cells
R Halaban et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors
MY Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
BJ Reinhart et al.
NATURE (2000)
Share Paper
